- Country: South Korea
- Summary: [Academic] Phase 1 Clinical Study on 3Rd Generation Smallpox/Monkeypox Vaccine Kvac103
- KRT Ref No: 95655208
- Deadline: 06 Mar 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 2863636364
- Notice Type: Tender
- Document Ref. No.: 20240122232-00
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- [Academic] Phase 1 clinical study on 3rd generation smallpox/monkeypox vaccine KVAC103
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN[Academic] Phase 1 Clinical Study on 3Rd Generation Smallpox/Monkeypox Vaccine Kvac103 - Korea Tender
The KOREA DISEASE CONTROL AND PREVENTION AGENCY, NATIONAL INSTITUTE OF HEALTH, a Government sector organization in South Korea, has announced a new tender for [Academic] Phase 1 Clinical Study on 3Rd Generation Smallpox/Monkeypox Vaccine Kvac103. This tender is published on KoreaTenders under KRT Ref No: 95655208 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-06.
The estimated tender value is KRW 2863636364, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
